Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 23548149
Novellasdemunt L, et al. (2013) PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli. Biochem J 452, 531-43 23548149
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T334-p - MAPKAPK2 (human)
Modsite: QstKVPQtPLHtsRV SwissProt Entrez-Gene
Orthologous residues
MAPKAPK2 (human): T334‑p, MAPKAPK2 iso2 (human): T334‑p, MAPKAPK2 (mouse): T320‑p, MAPKAPK2 (rat): T320‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
anisomycin increase

S461-p - PFKFB3 (human)
Modsite: NPLMRRNsVtPLAsP SwissProt Entrez-Gene
Orthologous residues
PFKFB3 (human): S461‑p, PFKFB3 iso4 (human): S475‑p, PFKFB3 (mouse): S461‑p, PFKFB3 (rat): S490‑p
Characterization
Methods used to characterize site in vivo mass spectrometry (in vitro), multiple reaction monitoring (MRM), phospho-antibody, phosphopeptide mapping, western blotting
Disease tissue studied:  glioblastoma multiforme, glioma, breast cancer
Relevant cell lines - cell types - tissues:  HEK293T (epithelial), HeLa (cervical), MCF-7 (breast cell), MEF (fibroblast), T98G (glial)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Enzymes shown to modify site in vitro
Type Enzyme
KINASE MAPKAPK2 (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE MAPKAPK2 (human) transfection of constitutively active enzyme, genetic knockout/knockin of upstream enzyme, transfection of inactive enzyme, activation of upstream enzyme, modification site within consensus motif, phospho-antibody, transfection of wild-type enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
hypertonic_buffer increase
anisomycin increase
PF3644022 anisomycin inhibit treatment-induced increase
PD98059 anisomycin, hypertonic_buffer no effect upon treatment-induced increase
SB203580 anisomycin, hypertonic_buffer inhibit treatment-induced increase
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced

S478-p - PFKFB3 (human)
Modsite: tKKPRINsFEEHVAS SwissProt Entrez-Gene
Orthologous residues
PFKFB3 (human): S478‑p, PFKFB3 iso4 (human): S492‑p, PFKFB3 (mouse): S478‑p, PFKFB3 (rat): S507‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
anisomycin no change compared to control

S103-p - SRF (human)
Modsite: RGLKRsLsEMEIGMV SwissProt Entrez-Gene
Orthologous residues
SRF (human): S103‑p, SRF (mouse): S99‑p, SRF (rat): S99‑p
Characterization
Methods used to characterize site in vivo phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  HeLa (cervical)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
anisomycin increase
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
Induces